Palomino Laboratories Stock Price, News & Analysis
Company Description
Palomino Laboratories (OTC Link: PALX) is a publicly traded company.
On a trailing twelve-month basis, Palomino Laboratories reported net income of -$3.2M and diluted earnings per share of $-0.47.
This page provides a comprehensive overview of PALX stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
PALX Rankings
Latest News
Palomino Laboratories has 2 recent news articles, with the latest published yesterday. View all PALX news →
SEC Filings
Palomino Laboratories has filed 3 recent SEC filings, including 2 Form 4, 1 Form 8-K. The most recent filing was submitted on April 24, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all PALX SEC filings →
Financial Highlights
operating income reached -$2.7M, and net income was -$3.2M. Diluted earnings per share stood at $-0.47. The company generated -$1.3M in operating cash flow. With a current ratio of 25.07, the balance sheet reflects a strong liquidity position.